[Therapy of acute occlusion of the retinal vessels with low-molecular dextran].
The use of low molecular dextran is a well established therapy for acute retinal vessel occlusion. This paper gives information about possible anaphylactoid reactions which may complicate the course of the disease.
D000208:Acute Disease; D000707:Anaphylaxis / Q000139:chemically induced; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D012171:Retinal Vessels
D003911:Dextrans
Beitrag zur Therapie akuter retinaler Gefässverschlüsse mit niedermolekularem Dextran.